Biogenesis is building the end-to-end platform for clinical research.
Biogenesis has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in March 2024.
Biogenesis's investors include Kleiner Perkins, Alt Capital, Greylock, Pareto Holdings, Cory Levy.
Biogenesis is headquartered in Palo Alto, United States.
Biogenesis is building the end-to-end platform for clinical research.
Biogenesis is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biogenesis — Funding & Investors." VCBacked, March 1, 2024, https://www.vcbacked.co/company/biogenesis. Accessed July 20, 2026.
VCBacked. (2024). Biogenesis — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biogenesis
{{cite web |title=Biogenesis — Funding & Investors |url=https://www.vcbacked.co/company/biogenesis |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated